Biliary Dyskinesia
Symptoms, Doctors, Treatments, Advances & More

Biliary Dyskinesia Overview

Save information for later
Sign Up

Learn About Biliary Dyskinesia

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Who are the top Biliary Dyskinesia Local Doctors?
Elite in Biliary Dyskinesia
Elite in Biliary Dyskinesia

Danbury Hospital

24 Hospital Ave, 
Danbury, CT 
Languages Spoken:
English

Stuart Sherman is a Radiologist in Danbury, Connecticut. Dr. Sherman is rated as an Elite provider by MediFind in the treatment of Biliary Dyskinesia. His top areas of expertise are Biliary Dyskinesia, Sphincter of Oddi Dysfunction, Pancreas Divisum, Endoscopy, and Lithotripsy.

Distinguished in Biliary Dyskinesia
Distinguished in Biliary Dyskinesia

Rayus/Foundation Radiology Group

6400 Brooktree Ct, Ste 350, 
Wexford, PA 
Languages Spoken:
English

. Dr. Blodgett is rated as a Distinguished provider by MediFind in the treatment of Biliary Dyskinesia. His top areas of expertise are Non-Alcoholic Fatty Liver Disease, Visceromegaly, Diverticular Disease, and Emphysema.

 
 
 
 
Learn about our expert tiers
Learn More
Distinguished in Biliary Dyskinesia
Distinguished in Biliary Dyskinesia

Rayus/Foundation Radiology Group

6400 Brooktree Ct, Ste 350, 
Wexford, PA 
Languages Spoken:
English

. Dr. Miller is rated as a Distinguished provider by MediFind in the treatment of Biliary Dyskinesia. His top areas of expertise are Gallbladder Disease, Diverticular Disease, Visceromegaly, and Non-Alcoholic Fatty Liver Disease.

What are the latest Biliary Dyskinesia Clinical Trials?
A Randomized, Open-label, Crossover Study to Assess the Comparative Pharmacokinetics, Bioequivalence, and Safety of Trimedat® 76,95 mg Orally Disintegrating Tablets and Trimedat® 100 mg Tablets in Healthy Volunteers.

Summary: This study aims to evaluate pharmacokinetic profile, safety and establish bioequivalence of the investigational drug Trimedat® 76,95 mg orally disintegrating tablets compared to the reference drug Trimedat® 100 mg tablets in healthy volunteers under fasted conditions.

Match to trials
Find the right clinical trials for you in under a minute
Get started
QST Study: Predicting Treatment Response in Chronic Pancreatitis Using Quantitative Sensory Testing

Summary: Quantitative Sensory Testing (QST) is a novel investigative technique used in other pain conditions to evaluate patterns of chronic pain, and in this study will be used to elucidate pain patterns in patients with Chronic Pancreatitis (CP). QST uses a specific series of standardized stimulations to map the pain system. QST has the potential to change and improve the treatment paradigm for patients ...